test

David Pezeshki

@Venbio Partners Llc

Latest period2024 - Q3ReportedManaged Assets$194.334MTotal holdings6
Assets growth rate-16.06%Assets growth rate (2-Q avg)-16.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Venbio Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 6 positions.

Assets under management

The assets under management (AUM) of Venbio Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 194.334M in assets, with a quarterly growth rate of -16.06% and a 2-quarter average growth rate of -16.96%. The portfolio is managed by David Pezeshki, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PHVSPharvaris N V
Recent Activity
40.88%
$79.438M
4.289M shares@ $18.52 avg price
ALMSAlumis Inc
Recent Activity
15.54%
$30.182M
2.826M shares@ $10.69 avg price
HRMYHarmony Biosciences Hldgs In
Recent Activity
Decreased -40.64%
12.66%
$24.584M
614,594 shares@ $40.0 avg price
ARTVArtiva Biotherapeutics Inc
Recent Activity
New Position
12.09%
$23.484M
1.52M shares@ $15.46 avg price
SLRNAcelyrin Inc
Recent Activity
9.78%
$18.993M
3.852M shares@ $4.93 avg price
ALXOAlx Oncology Hldgs Inc
Recent Activity
9.09%
$17.654M
9.7M shares@ $1.83 avg price